MIKS Trademark

Trademark Overview


On Friday, April 28, 2023, a trademark application was filed for MIKS with the United States Patent and Trademark Office. The USPTO has given the MIKS trademark a serial number of 97911902. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Tuesday, July 2, 2024. This trademark is owned by Emmetrope Ophthalmics LLC. The MIKS trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Biological tissue cultures for medical purposes; Biological tissue grafts; Biological implants, namely, a vital processed human or animal connective tissue; Biological cultured tissue for medical purposes intended for subsequent implantation

Medical services relating to the removal, treatment and processing of human cells; Medical treatment using cultured cells; Regenerative medicine services; Consulting in the fields of ophthalmology and health as it relates to cell therapy
miks

General Information


Serial Number97911902
Word MarkMIKS
Filing DateFriday, April 28, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateTuesday, July 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBiological tissue cultures for medical purposes; Biological tissue grafts; Biological implants, namely, a vital processed human or animal connective tissue; Biological cultured tissue for medical purposes intended for subsequent implantation
Goods and ServicesMedical services relating to the removal, treatment and processing of human cells; Medical treatment using cultured cells; Regenerative medicine services; Consulting in the fields of ophthalmology and health as it relates to cell therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 26, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 18, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEmmetrope Ophthalmics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 94025

Trademark Events


Event DateEvent Description
Tuesday, May 2, 2023NEW APPLICATION ENTERED
Friday, May 26, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 16, 2024ASSIGNED TO EXAMINER
Tuesday, January 23, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 23, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 16, 2024NON-FINAL ACTION WRITTEN
Tuesday, April 16, 2024NON-FINAL ACTION E-MAILED
Tuesday, April 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 2, 2024FINAL REFUSAL E-MAILED
Tuesday, June 4, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 4, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 2, 2024FINAL REFUSAL WRITTEN
Thursday, September 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 12, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, July 2, 2024NOTIFICATION OF FINAL REFUSAL EMAILED